Revive Therapeutics in Agreement With Defence Research and Development Canada to Evaluate Bucillamine for Nerve Agent Exposure
Revive Therapeutics in Agreement With Defence Research and Development Canada to Evaluate Bucillamine for Nerve Agent Exposure
Revive Therapeutics与加拿大国防研究与发展部达成协议，评估布西拉明对神经毒剂暴露的影响
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册